Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy; Evidence That TRAb May Precede Thyroid Dysfunction by Many Years
Thyroid - United States
doi 10.1089/thy.2018.0232
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Mary Ann Liebert Inc